2023
Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study
Clegg K, Schubert T, Block R, Burke F, Desai N, Greenfield R, Karalis D, Kris-Etherton P, McNeal C, Nahrwold R, Peña J, Plakogiannis R, Wong N, Jones L. Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study. Journal Of Clinical Lipidology 2023, 17: 592-601. PMID: 37550150, DOI: 10.1016/j.jacl.2023.07.007.Peer-Reviewed Original ResearchConceptsAtherosclerotic cardiovascular diseaseEvidence-based guidelinesASCVD patientsDetailed patient historyCause of deathClinical best practicesBetter patient careEvidence-based managementU.S. health systemEvidence-based approachOptimal careCardiovascular diseasePatient historyDiagnostic criteriaClinician groupsField of lipidologyPatient careHealth systemCliniciansPatientsCarePilot testingGuidelinesFocus groupsElicit feedback
2020
Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
Khera R, Valero-Elizondo J, Nasir K. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions. Journal Of The American Heart Association 2020, 9: e017793. PMID: 32924728, PMCID: PMC7792407, DOI: 10.1161/jaha.120.017793.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAtherosclerotic cardiovascular diseaseFinancial toxicitySubstantial economic impactCost sharingHigh deductiblesNational expenditureEconomic impactPolicy circlesPocket costsFinancial impactHealthcare expendituresHealth careASCVD patientsWell tradeoffCardiovascular diseaseExpenditureNecessary medical care
2018
Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
Okunrintemi V, Valero‐Elizondo J, Patrick B, Salami J, Tibuakuu M, Ahmad S, Ogunmoroti O, Mahajan S, Khan SU, Gulati M, Nasir K, Michos ED. Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease. Journal Of The American Heart Association 2018, 7: e010498. PMID: 30561253, PMCID: PMC6405598, DOI: 10.1161/jaha.118.010498.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAtherosclerosisCross-Sectional StudiesFemaleHealth CommunicationHealth Knowledge, Attitudes, PracticeHealth Status DisparitiesHealthcare DisparitiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPatient Reported Outcome MeasuresPatient SatisfactionPhysician-Patient RelationsPlatelet Aggregation InhibitorsQuality of LifeRetrospective StudiesRisk FactorsSex FactorsUnited StatesYoung AdultConceptsHealth-related qualityBackground Atherosclerotic cardiovascular diseaseLower health-related qualityAtherosclerotic cardiovascular diseasePatient experienceCardiovascular diseaseHealth outcomesPoor patient-provider communicationImportant public health implicationsSelf-reported patient experienceNinth Revision codesPatient-centered outcomesPatient-reported outcomesPatient-provider communicationThird of deathsPoor perceptionPoor patient experiencePositive patient experiencePublic health implicationsMedical Expenditure PanelPerception of healthGender-specific differencesRepresentative US sampleGender differencesASCVD patients
2017
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey
Salami JA, Valero‐Elizondo J, Ogunmoroti O, Spatz ES, Rana JS, Virani SS, Blankstein R, Younus A, Arrieta A, Blaha MJ, Veledar E, Nasir K. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey. Journal Of The American Heart Association 2017, 6: e004996. PMID: 28600400, PMCID: PMC5669151, DOI: 10.1161/jaha.116.004996.Peer-Reviewed Original ResearchConceptsModifiable risk factorsAtherosclerotic cardiovascular diseaseCardiovascular diseaseRisk factorsPharmaceutical expenditureMedication-related expendituresSignificant marginal increaseSurvey's complex designInadequate physical activityMedical Expenditure Panel SurveyMedical Expenditure PanelHigher healthcare spendingASCVD patientsDiabetes mellitusMost deathsPhysical activityTotal pharmaceutical expenditureAdjusted relationshipMedicationsDiseaseHealthcare spendingMellitusPatientsAssociationAdults
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply